Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Renowned Speakers

Feng Yan

Feng Yan

Nanjing Medical University Cancer China

Fikri Selcuk Simsek

Fikri Selcuk Simsek

Firat University Turkey

Franco Maria Buonaguro

Franco Maria Buonaguro

Istituto Nazionale Tumori Italy

Fredy Ariza Cadena

Fredy Ariza Cadena

Universidad ICESI and Universidad del Valle Colombia

George Peery

George Peery

Dean University of Texas USA

Gia Nemsadze

Gia Nemsadze

The Institute of Clinical Oncology Georgia

Giulio Tarro

Giulio Tarro

Foundation de Beaumont Bonelli for Cancer Research Italy

Graciela Ghirardi

Graciela Ghirardi

Córdoba Hospital Argentina

Euro Cancer 2019

About Conference


On behalf of Scientfic Organising Committee we are overwhelmed to welcome all the interested participants to attend 34th Euro-Global Summit on Cancer Therapy & Radiation Oncology during July 25-27, 2019 at London, UK

The conference will be organized around the theme: Advancement in Cancer Research and Prospects of New Therapeutic Strategies

Euro Cancer 2019 is a three day event consisting of a lettered scientific program, laudable talks by the top notch of the global scientific community, that brings together active researchers, intellectuals, academicians, students, contributors and industrialists to exchange ideas communicate and discuss research findings on new advancements in all kinds of available cancer therapies worldwide innovative research products which can be exhibited for further development in Oncology. This UK Cancer Congress is going to be the largest and most promising international conference that specifically focuses on the Radiation therapy by bringing all Renowned Radiation Oncologists under one roof. This is a three day multidisciplinary meeting covering all aspects of Cancer Therapies and Radiation Oncology, including clinical service delivery, management, informatics and research.

Cancer therapy describes the treatment of cancer in a patient, some people with cancer are treated with only one type of treatment. A cancer patient might receive many different types of therapy, including those aimed at relieving the symptoms of cancer, such as pain. But most people have a combination of treatments, like surgery with chemotherapy or radiation therapy

Radiation Oncology is a medical specialty that involves treating cancer with radiation. Doctors who specialize in treating cancer with radiation (radiation oncologists) use radiation therapy to treat a wide variety of cancers. Radiation therapy uses carefully targeted and regulated doses of high-energy radiation to kill cancer cells. Radiation kills cancer cells by damaging the chromosomes and DNA so that the cells can no longer divide and the tumor can't grow. The discussion extends to all available Cancer Therapies like Surgical Therapy, Chemotherapy, Adjuvant Therapy, Neoadjuvant Therapy, Immunotherapy, Hormonal Therapy, Proton Beam Therapy, Phototherapy, Stem Cell Therapy and Alternative Medicine.

Hall marks of Conference:

Principles of Cancer therapy
Radiation Oncology and Recent advances in Radiation therapy
Cancer Chemotherapeutic Drugs
Uses of Surgical Oncology
Adjuvants, Neoadjuvants and Palliative treatment in cancer
Multimodality treatment in Cancer
Cancer Screening and Diagnostic Tests
Complementary and Alternative Cancer Medicine
Prophylactic and therapeutic Cancer Vaccines

Target Audience:

Oncologists
Radiologists
Chemotherapists
Cancer Researchers
Oncology Institutes
Medical Colleges
Research faculty
Academic Scientists
Young Researchers
Cancer Diagnostics Associations and Societies
Diagnostic laboratory professionals
Business Entrepreneurs
Industry professionals
Directors/Managers/CEO
Presidents & Vice Presidents
Brand Manufacturers/ Marketers of Consumer Products
Marketing, Advertising and Promotion Agency Executives

 

Sessions/Tracks

Track 1: Cancer

Cancers may be benign or malignant. Benign cancers fail to spread to other tissues and is non-life threatening. Malignant Tumors are invasive and spread to different tissues within the area. Diverse kinds of tumors are present till date and many are beneath research investigation. Most cancers are a disease involving abnormal cell growth spread to different parts of the body. There are over distinct varieties of cancer, they may be divided into groups, each is assessed with the aid of the type of cell this is first affected. Cancer harms the body while cells divide uncontrollably to form masses or lumps of tissue this will cause an increase known as a tumour. A few Tumors are named after discoverer, which include Wilm's Tumour (a childhood kidney cancer), Hodgkin’s disorder (a form of lymphoma), and Kaposi’s sarcoma (cancer of blood vessels, uncommon besides associated with immunodeficiency and HIV contamination). Some Cancers are divided into groups according to the type of cell they start from.

  • Carcinomas are cancers of epithelial cells
  • Sarcomas represent tumors of connective tissues
  • Leukaemia  and Lymphomas refer to Cancers of blood cells

European Oncology Societies: European Society for Gene and Cell TherapyInternational Society for Stem Cell Research (ISSCR)UK Oncology Nursing Children’s Cancer and Leukemia Group SocietyEuropean Society of Oncologic ImagingEuropean Association for Cancer Research

USA Oncology Societies: American Cancer Society (ACS)American Association for Cancer Research (AACR)International Agency for Research on Cancer (IARC)American Society of Clinical Oncology (ASCO)

Asian Oncology Societies: Asian Oncology Nursing Society (AONS)Asian Society of Gynecologic Oncology (ASGO)Asian Society of Head & Neck Oncology (ASHNO)Federation of Asian Organizations for Radiation Oncology (ARO)

Track 2: Cancer Therapy

There are more than 200 types of cancer, including Breast cancer, skin cancer, lung cancer, colon cancer, Prostate cancer, and lymphoma. Symptoms and Treatment varies depending on the type of Cancer. Some people with cancer will have only one treatment. But most people have a combination of treatments, such as surgery with chemotherapy and/or radiation therapy. The Anticancer therapies include Surgical therapy, Chemotherapy, Adjuvant therapy, Neoadjuvant therapy, Palliative therapy, Immunotherapy, Hormonal therapy, Radiotherapy, Nutritional therapy, Phototherapy. Phototherapy / proton beam therapy is the most advanced among all the therapies. All Anticancer agents act by disturbing cell multiplication or normal functioning, DNA synthesis or chromosomal migration, and by blocking or changing RNA and protein metabolism. There are various techniques used in the treating the cancers such as various surgeries were used to done for the treating or removing the cancer cells. Various therapies has been followed by the implementation of the new drug by clinical trials results , or by passing the cell under some radiations or radioactive waves or by taking some sort of medicine or dealing with the alteration in the genetic material or by some sort of particular organ transplant.

European Oncology Societies: European Association for Cancer ResearchEuropean Association of Neuro-OncologyDutch Society for Surgical OncologyGerman Society of Radiation OncologyChildhood Cancer Research GroupAssociation of Population-based Cancer Registries in GermanyFrench Society of Radiation OncologyChildren's Cancer Association.

USA Oncology Societies: Colon Cancer AllianceAmerican Childhood Cancer AssociationAmerican Society for Radiation OncologyChildren's Neuroblastoma Cancer FoundationMusculoskeletal Tumor Society.

Asian Oncology Societies: Singapore Society of OncologyAssociation of Radiation Oncologists of IndiaJapanese Breast Cancer SocietyAsian Cancer FoundationJapan Lung Cancer SocietyCancer Relief Society Nepal.

Track 3: Organ Specific Cancers

Cancer can occur anywhere in the body. The most common sites of cancer among men include lung, prostate, colon, rectum, stomach and liver. And those for among women are breast, colon, rectum, lung, cervix and stomach. Cancers are often described by the body part that they originated in. However, some body parts contain multiple types of tissue, so for greater precision, cancers can additionally be classified by the type of cell that the tumour cells originated from. The type of cancer a person has needed to be known properly as different types of cancer can behave very differently and respond to different treatments. Cancer is one of the leading causes of death all over the world. Organ Specific Cancers are cancers named based on the location of cancer in the body organ. Its incidence is showing an increasing trend in various parts of the earth and has been a significant public health problem despite advances in the understanding of the molecular and cellular events that underlie.

European Oncology Societies: European Society for Gene and Cell TherapyInternational Society for Stem Cell Research (ISSCR)UK Oncology Nursing Children’s Cancer and Leukemia Group SocietyDutch Society for Surgical OncologyGerman Society of Radiation OncologyChildhood Cancer Research Group

USA Oncology Societies: American Cancer Society (ACS)American Association for Cancer Research (AACR)International Agency for Research on Cancer (IARC)American Society of Clinical Oncology (ASCO)Society of Surgical Oncology (SSO)Colon Cancer AllianceAmerican Childhood Cancer Association

Asian Oncology Societies: Asian Oncology Nursing Society(AONS)Asian Society of Gynecologic Oncology (ASGO)Federation of Asian Organizations for Radiation Oncology (ARO)Association of Radiation Oncologists of IndiaJapanese Breast Cancer SocietyAsian Cancer FoundationCancer Relief Society Nepal.

Track 4: Cancer Science

Cancer Science is a medical field that covers every branch of cancer research and therapy. Cancer was considered as deadly disease few years ago, but now the development has changed thanks to advances made in the cancer field. There are diverse therapies available now to treat and diagnose cancer. The Targeted Cancer Therapy is one of the best therapies available, in which the cancer cells are treated by targeting and inhibiting specific molecules that are responsible for tumor progression. This blocking can be done by medicine. The Cancer Case Reports shows that Stem Cell Therapy is also an effective treatment for cancer. Cancer biomarkers assist in finding tumor cells and treating them. Tumor Immunology plays an important role in verdict of new approaches for cancer therapeutics.

European Oncology Societies: European Society for Gene and Cell TherapyInternational Society for Stem Cell Research (ISSCR)European Society of Oncologic ImagingGerman Society of Radiation OncologyChildhood Cancer Research GroupAssociation of Population-based Cancer Registries in Germany

USA Oncology Societies: American Cancer Society (ACS)American Association for Cancer Research (AACR)International Agency for Research on Cancer (IARC)American Society of Clinical Oncology (ASCO)Society of Surgical Oncology (SSO)Colon Cancer AllianceAmerican Childhood Cancer Association

Asian Oncology Societies: Federation of Asian Organizations for Radiation Oncology (ARO), Singapore Society of OncologyAssociation of Radiation Oncologists of IndiaJapanese Breast Cancer SocietyAsian Cancer FoundationJapan Lung Cancer Society

Track 5: Cancer Biomarkers

A cancer biomarker refers to an element or procedure that is indicative of the presence of cancer in the body. A biomarker may be a molecule released by a presence of tumour or a specific response of the body to the presence of cancer. Cancer biomarkers are usually biological molecules found in blood, other body fluids, or tissues that are a sign of a normal or abnormal process, or of a condition or disease. Genetic, epigenetic, proteomic, glycomic, and imaging biomarkers can be used for cancer diagnosis, prognosis and epidemiology. The most promising use of biomarkers today is to identify which therapies a patient’s cancer may or may not respond to. So many pharmaceutical companies were producing different sort of biomarkers. So it plays a vital role in the treatment in cancer.

European Oncology Societies: European Society for Gene and Cell TherapyInternational Society for Stem Cell Research (ISSCR)Association of Population-based Cancer Registries in GermanyFrench Society of Radiation OncologyChildren's Cancer Association

USA Oncology Societies: American Cancer Society (ACS)American Association for Cancer Research (AACR)Society of Surgical Oncology (SSO)Colon Cancer AllianceAmerican Childhood Cancer AssociationAmerican Society for Radiation Oncology

Asian Oncology Societies: Asian Oncology Nursing Society(AONS)Asian Society of Gynecologic Oncology (ASGO)Asian Society of Head & Neck Oncology (ASHNO)Singapore Society of OncologyAssociation of Radiation Oncologists of IndiaJapanese Breast Cancer SocietyCancer Relief Society Nepal.

Track 6: Cancer Diagnosis

Diagnostics plays an important role throughout Cancer treatment. Before treatment, to accurately locate Tumors, stage the disease, and determine an appropriate combination of cancer treatments. Diagnostics are used to track the size of the tumor, progression of the disease, and patient response to treatment, and modify your treatment accordingly. To confirm the diagnosis of most cancers, a Biopsy needs is to be performed in which a tissue sample is removed from the suspected tumour which occurred initially and studied under a microscope for detecting cancer cells. Endoscopy can be done by inserting a flexible plastic tube with a tiny camera into body cavities or organs. Screening tests are used to detect the possibility of a cancer which is present before symptoms occur. To identify cancer at its initial stage, different types of cancer diagnostic tests are used to Screen at-risk individuals, Monitor treatment efficacy and disease progression or recurrence, Predict prognosis and direct treatment, Screen an asymptomatic population for the early detection of cancer, Earlier detection and treatment subsequently decreases cancer mortality, Diagnose a primary cancer and identify the cancer subtype after complete cancer treatment, to monitor for any signs of metastasis or recurrence.

European Oncology Societies: Dutch Society for Surgical OncologyGerman Society of Radiation OncologyChildhood Cancer Research GroupAssociation of Population-based Cancer Registries in GermanyFrench Society of Radiation OncologyChildren's Cancer Association

USA Oncology Societies: American Cancer Society (ACS)American Association for Cancer Research (AACR)International Agency for Research on Cancer (IARC)American Society of Clinical Oncology (ASCO)Society of Surgical Oncology (SSO)Colon Cancer Alliance

Asian Oncology Societies: Asian Society of Gynecologic Oncology (ASGO)Association of Radiation Oncologists of IndiaJapanese Breast Cancer SocietyAsian Cancer FoundationJapan Lung Cancer SocietyCancer Relief Society Nepal

Track 7: Radiation Oncology

The branch of Oncology dealing with Radiation therapy is termed as Radiation Oncology. Radiation oncology is a medical arena that involves the controlled use of radiation to treat cancer either for cure or to reduce pain and symptoms caused by cancer. Radiation Oncology encompasses all aspects of research that impacts on the treatment of cancer using radiation. Radiation can be given as a curative modality, either alone or in combination with surgery or chemotherapy. It may also be used palliatively, to relieve symptoms in patients with incurable cancers. The Radiation therapy and/or radiotherapy are broadly segmented into Brachy-radiotherapyTeleradiotherapy and Metabolic Radiotherapy. There are three unique Radiology specialist professions which are involved in practice of radiation oncology 1. Radiation Oncologists 2. Radiation Therapists 3. Radiation Oncology Medical Physicists. These highly trained medical specialists who use advanced technologies on Cancer patients to deliver safe and effective radiation therapy with few side effects as possible.

European Oncology Societies: International Society for Stem Cell Research (ISSCR)European Society of Oncologic ImagingEuropean Association for Cancer ResearchAssociation of Population-based Cancer Registries in GermanyFrench Society of Radiation OncologyChildren's Cancer Association

USA Oncology Societies: American Cancer Society (ACS)American Association for Cancer Research (AACR)American Childhood Cancer AssociationAmerican Society for Radiation OncologyChildren's Neuroblastoma Cancer FoundationMusculoskeletal Tumor Society

Asian Oncology Societies: Asian Oncology Nursing Society(AONS)Federation of Asian Organizations for Radiation Oncology (ARO)Singapore Society of OncologyAssociation of Radiation Oncologists of IndiaJapanese Breast Cancer SocietyAsian Cancer FoundationJapan Lung Cancer Society

Track 8: Radiation Therapy

Use of Radiation to kill diseased cells has become a standard treatment option for a wide range of malignancies. It utilizes X-rays, gamma rays, electron beams or protons to treat cancer. Radiotherapy can be used in three modalities: – Curative radiotherapy; Adjuvant radiotherapy and Palliative radiotherapy. Among all the available Anti-cancer therapies, Radiation therapy is the most conventional method of treating Cancers. Success depends on early diagnosis, the volume and histological nature of the tumor. Techniques in Radiation therapy include  Triggered imaging radiosurgery, Gamma Knife surgery, Medical dosimetry, Three-Dimensional Conformal Radiation Therapy, Brachytherapy, External Beam Radiation Therapy, Image-Guided Radiotherapy, Intensity Modulated Radiation Therapy, radioisotope therapy, Stereotactic body radiation therapy, Total Body Irradiation, and Total Skin Irradiation.

European Oncology Societies: International Society for Stem Cell Research (ISSCR)European Society of Oncologic ImagingEuropean Association for Cancer ResearchEuropean Association of Neuro-OncologyAssociation of Population-based Cancer Registries in GermanyFrench Society of Radiation Oncology

USA Oncology Societies: American Cancer Society (ACS)International Agency for Research on Cancer (IARC)Society of Surgical Oncology (SSO)Colon Cancer AllianceAmerican Childhood Cancer AssociationAmerican Society for Radiation OncologyMusculoskeletal Tumor Society

Asian Oncology Societies: Asian Oncology Nursing Society (AONS)Asian Society of Head & Neck Oncology (ASHNO)Japanese Breast Cancer SocietyAsian Cancer FoundationJapan Lung Cancer SocietyCancer Relief Society Nepal

Track 9: Nuclear Medicine

Nuclear medicine is a department of medicine that makes use of radiation to provide information approximately the functioning of a person's unique organs or to deal with sickness along with the utilization of radioactive materials within the finding and treatment of sickness. It is known as nuclide imaging. Diagnostic techniques in nuclear medicinal drug use radioactive tracers which emit gamma rays from within the body. The gamma camera builds up an image from the factors where the radiation is emitted. This image is enhanced by a computer and viewed by a physician on a monitor for indications of abnormal conditions.  Single photon emission computed tomography SPECT and Positron Emission Tomography or PET scans are the 2 most common imaging modalities in nuclear medicine. It is used in diagnosis of HuntingtonAlzheimer, Parkinson diseases, brain perfusion, myocardial perfusion, tumour detection or metastases.

European Oncology Societies: Dutch Society for Surgical OncologyGerman Society of Radiation OncologyChildhood Cancer Research GroupAssociation of Population-based Cancer Registries in GermanyFrench Society of Radiation OncologyChildren's Cancer Association

USA Oncology Societies: American Society of Clinical Oncology (ASCO)Society of Surgical Oncology (SSO)Colon Cancer AllianceAmerican Childhood Cancer AssociationChildren's Neuroblastoma Cancer FoundationMusculoskeletal Tumor Society

Asian Oncology Societies: Singapore Society of OncologyAssociation of Radiation Oncologists of IndiaJapanese Breast Cancer SocietyAsian Cancer FoundationJapan Lung Cancer SocietyCancer Relief Society Nepal

Track 10: Medical Imaging

Medical imaging is the technique and process of creating visual representations of the interior of a body for clinical analysis and medical intervention, as well as visual representation of the function of some organs or tissues. Imaging technologies include X-ray imagingComputed tomography, Planar scintigraphy, Imaging modalities, Emission tomography, Magnetic Resonance Imaging, Multimodal systems. It helps in diagnosis of Cancer, Cardiovascular disease, Neurological disorders (e.g., Alzheimer’s disease) and in drug development via small animal imaging with micro PET or micro SPECT, micro CT, micro MRI, bioluminescence and fluorescence imaging systems.

European Oncology Societies: European Society for Gene and Cell TherapyInternational Society for Stem Cell Research (ISSCR)European Society of Oncologic ImagingDutch Society for Surgical OncologyGerman Society of Radiation OncologyAssociation of Population-based Cancer Registries in GermanyFrench Society of Radiation Oncology

USA Oncology Societies: American Cancer Society (ACS)American Association for Cancer Research (AACR)American Society of Clinical Oncology (ASCO)Society of Surgical Oncology (SSO)American Childhood Cancer AssociationAmerican Society for Radiation OncologyChildren's Neuroblastoma Cancer Foundation

Asian Oncology Societies: Asian Oncology Nursing Society (AONS)Asian Society of Gynecologic Oncology (ASGO)Asian Society of Head & Neck Oncology (ASHNO)Federation of Asian Organizations for Radiation Oncology (ARO)

Track 11: Chemotherapy

Cancer chemotherapy involves the selection of drugs and dose levels, which will eradicate disseminated cancer cells, without causing severe host toxicity. Depending on the primary location and the extension of the disease, chemotherapy can be curative or palliative. In the majority of cases, Chemotherapy leads to the prolongation of survival, and in other cases it results in the eradication of the disease. Chemotherapy can be in most cases a major adjuvant to surgical therapy and/or radiotherapy. It is most successful against Leukemias. Mechanism-based approaches have also been explored for several decades. About 30 chemotherapeutic drugs are in regular use in the treatment of cancer till date. All Antitumor drugs may be placed into one of three classes based on the relationship of the effect to the mitotic cycle of the cell:

1. Cell cycle active, phase specific
2. Cell cycle active, phase non-specific
3. Non-cell cycle active.

European Oncology Societies: European Society for Gene and Cell TherapyInternational Society for Stem Cell Research (ISSCR)UK Oncology Nursing Children’s Cancer and Leukemia Group SocietyEuropean Society of Oncologic ImagingEuropean Association for Cancer Research

USA Oncology Societies: American Society of Clinical Oncology (ASCO)Society of Surgical Oncology (SSO)Colon Cancer AllianceAmerican Childhood Cancer AssociationAmerican Society for Radiation OncologyChildren's Neuroblastoma Cancer Foundation

Asian Oncology Societies: Federation of Asian Organizations for Radiation Oncology (ARO)Singapore Society of OncologyAssociation of Radiation Oncologists of IndiaJapanese Breast Cancer SocietyAsian Cancer FoundationJapan Lung Cancer Society

Track 12: Cancer Immunology & Immunotherapy

Cancers immunology is a branch of immunology that describes about the research interactions among the immune system and cancer cells. Its field of study that goals to find out cancer immunotherapies to deal with and retard progression of the Disease. Cancer immunotherapy additionally called immuno-oncology is using the immune device to treat cancer. Immunology may be categorized as active, passive or hybrid (active and passive). The immune response, along with the recognition of most cancers-specific antigens, forms the basis of targeted therapy (along with vaccines and antibody procedures) and tumour marker-based diagnostic tests.

European Oncology Societies: European Society for Gene and Cell TherapyInternational Society for Stem Cell Research (ISSCR)European Society of Oncologic ImagingEuropean Association for Cancer Research,  Dutch Society for Surgical OncologyGerman Society of Radiation OncologyChildren's Cancer Association

USA Oncology Societies: American Cancer Society (ACS)American Association for Cancer Research (AACR) Society of Surgical Oncology (SSO)Colon Cancer AllianceAmerican Childhood Cancer AssociationAmerican Society for Radiation OncologyMusculoskeletal Tumor Society

Asian Oncology Societies: Asian Oncology Nursing Society(AONS)Asian Society of Gynecologic Oncology (ASGO)Asian Society of Head & Neck Oncology (ASHNO)Singapore Society of OncologyAsian Cancer FoundationJapan Lung Cancer SocietyCancer Relief Society Nepal

Track 13: Cancer Stem Cell Therapy

Cancer Stem-cell therapy is the use of stem cells to treat or prevent a disease or a condition. Stem Cells and Tumours cancer cells also have the characteristic which is also associated with normal stems cells. Stems cells transplant is used for the treatment of cancer like leukaemia, lymphoma and multiple myeloma. Additionally, stem cells can be applied in regenerative medicine, cancer stem cell-targeted therapy, immunotherapy and anticancer drug screening applications. However, while using stem cells to treat human cancers appears technically feasible, challenges such as treatment durability and tumorigenesis necessitate further study to improve therapeutic applicability and performance

European Oncology Societies: International Society for Stem Cell Research (ISSCR)UK Oncology Nursing Children’s Cancer and Leukemia Group Society,  German Society of Radiation OncologyChildhood Cancer Research GroupAssociation of Population-based Cancer Registries in Germany

USA Oncology Societies: American Cancer Society (ACS)American Association for Cancer Research (AACR)American Society of Clinical Oncology (ASCO)Colon Cancer AllianceAmerican Childhood Cancer AssociationAmerican Society for Radiation OncologyChildren's Neuroblastoma Cancer Foundation

Asian Oncology Societies: Asian Society of Gynecologic Oncology (ASGO)Asian Society of Head & Neck Oncology (ASHNO)Federation of Asian Organizations for Radiation Oncology (ARO), Singapore Society of OncologyAssociation of Radiation Oncologists of IndiaJapanese Breast Cancer SocietyCancer Relief Society Nepal.

Track 14: Cancer Epidemiology

Cancer Epidemiology is a branch of science that deals with factors affecting cancer, to infer possible trends and causes, the cancer distribution, incidence and prevention of disease and other factors related to health. The ultimate goal is to identify the major risk factors they may lead to effective preventive measures to identify and develop improved treatments. It represents the study of factors responsible that are for the initiation, metastasis and prognosis of various types of cancer to identify events that increase or decrease cancer incidence in specific populations. Epidemiological research findings on cancer lead to the formulation of suitable therapeutic treatment methods and preventive medicines for cancer.

European Oncology Societies: European Society for Gene and Cell TherapyEuropean Society of Oncologic ImagingEuropean Association for Cancer ResearchEuropean Association of Neuro-OncologyAssociation of Population-based Cancer Registries in GermanyFrench Society of Radiation OncologyChildren's Cancer Association

USA Oncology Societies: American Cancer Society (ACS)American Association for Cancer Research (AACR)International Agency for Research on Cancer (IARC)American Society of Clinical Oncology (ASCO)American Society for Radiation OncologyChildren's Neuroblastoma Cancer FoundationMusculoskeletal Tumor Society

Asian Oncology Societies: Federation of Asian Organizations for Radiation Oncology (ARO)Singapore Society of OncologyAsian Cancer Foundation, Japan Lung Cancer SocietyCancer Relief Society Nepal

Track 15: Cancer Genetics

Cancer is a genetic disease caused by changes in certain genes that control the way of our cells function particularly how they develop and divide. Genes carry the guiding principle to make proteins, which do much of the work in our cells. Certain changes in gene can cause cells to evade normal development control and become cancer. Few cancer-causing gene changes increase production of a protein that makes cells grow. Others result in the production of a misshapen, and therefore non-functional, form of a protein that normally repairs cellular damage.

European Oncology Societies: European Society for Gene and Cell TherapyInternational Society for Stem Cell Research (ISSCR)UK Oncology Nursing Children’s Cancer and Leukemia Group SocietyEuropean Society of Oncologic ImagingEuropean Association for Cancer ResearchEuropean Association of Neuro-Oncology

USA Oncology Societies: American Cancer Society (ACS)American Association for Cancer Research (AACR)International Agency for Research on Cancer (IARC)American Society of Clinical Oncology (ASCO)Society of Surgical Oncology (SSO)Colon Cancer Alliance

Asian Oncology Societies: Asian Oncology Nursing Society (AONS)Asian Society of Gynecologic Oncology (ASGO)Asian Cancer FoundationJapan Lung Cancer SocietyCancer Relief Society Nepal

Track 16: Nanotechnology in Cancer

Research on nanotechnology most cancers therapy extends beyond drug transport into the advent of latest therapeutics available best via use of nanomaterial houses. Even though nano particles are small as compared to cells, nanoparticles are massive sufficient to encapsulate many small molecule compounds, which can be of a couple of kinds. On the equal time, the extraordinarily large floor place of nanoparticle can be functionalized with ligands, together with small molecules, DNA or RNA strands, peptides, aptamers or antibodies. These ligands may be used for healing impact or to direct nanoparticle destiny in vivo. These properties permit aggregate drug delivery, multi-modality treatment and mixed healing and diagnostic, referred to as “Theranostic,” motion. The physical properties of nanoparticles, together with electricity absorption and re-radiation, can also be used to disrupt diseased tissue, as in laser ablation and hyperthermia programs

European Oncology Societies: European Association for Cancer ResearchEuropean Association of Neuro-OncologyDutch Society for Surgical OncologyGerman Society of Radiation OncologyChildhood Cancer Research GroupAssociation of Population-based Cancer Registries in Germany

USA Oncology Societies: American Cancer Society (ACS)American Association for Cancer Research (AACR)International Agency for Research on Cancer (IARC)American Society of Clinical Oncology (ASCO)

Asian Oncology Societies: Asian Oncology Nursing Society (AONS)Asian Oncology Nursing Society (AONS)Asian Society of Gynecologic Oncology (ASGO)Asian Society of Head & Neck Oncology (ASHNO)Federation of Asian Organizations for Radiation Oncology (ARO)

Track 17: Cancer Drugs

Cancer or its treatment can lower your resistance to infection and make you more likely to catch the other diseases. There are many different types of cancer drugs. Some drugs can treat cancer and the others help to relieve symptoms such as pain and sickness. The type of drugs you need to use for cure of your cancer depends on what type of cancer you have. Drug therapies work in diverse ways to destroy cancer cells and stop them from spreading or slow down their development. Anticancer drugs or anticancer agents are used in Cancer. Drugs may also be used to reduce or relieve side effects of cancer and its treatment.

European Oncology Societies: European Society for Gene and Cell TherapyInternational Society for Stem Cell Research (ISSCR)UK Oncology Nursing Children’s Cancer and Leukemia Group SocietyChildhood Cancer Research GroupAssociation of Population-based Cancer Registries in GermanyChildren's Cancer Association

USA Oncology Societies: American Cancer Society (ACS)American Association for Cancer Research (AACR)American Childhood Cancer AssociationAmerican Society for Radiation OncologyChildren's Neuroblastoma Cancer Foundation

Asian Oncology Societies: Asian Oncology Nursing Society(AONS)Asian Society of Gynecologic Oncology (ASGO)Japanese Breast Cancer SocietyAsian Cancer FoundationJapan Lung Cancer SocietyCancer Relief Society Nepal

Track 18: Cancer Vaccines

Cancer Vaccines typically either treats existing cancer or prevents development of a cancer. The drug is useful in treating the cancer. It’s been classified into many categories which incorporates natural product, alkylating agents, hormonesantimetabolites. Cancer treatment vaccines are created of cancer cells, elements of cells, or pure antigens. Typically a patient’s own immune cells are removed and exposed to those substances within the research laboratory to make the vaccines. Therapeutic vaccines represent a viable possibility for active therapy of cancers that aim to treat late stage of cancer by employing a patient's own system.

European Oncology Societies: European Society for Gene and Cell TherapyInternational Society for Stem Cell Research (ISSCR)UK Oncology Nursing Children’s Cancer and Leukemia Group SocietyEuropean Society of Oncologic ImagingEuropean Association for Cancer Research

USA Oncology Societies: American Cancer Society (ACS)American Association for Cancer Research (AACR)International Agency for Research on Cancer (IARC)American Society of Clinical Oncology (ASCO)Society of Surgical Oncology (SSO)Colon Cancer Alliance

Asian Oncology Societies: Asian Oncology Nursing Society (AONS)Asian Society of Gynecologic Oncology (ASGO)Asian Society of Head & Neck Oncology (ASHNO)Federation of Asian Organizations for Radiation Oncology (ARO)

Track 19: Cancer Alternative Medicine

Cancer Alternative Medicine includes Complementary and Alternative Medicine, which are generally non mainstream practices. Recently Cancer Alternative Medicine therapies are gaining importance in managing adverse symptoms of Cancer. If a non-mainstream treatment is used together with conventional medicine, it’s considered as “Complementary treatment.” If a non-mainstream treatment is used in place of conventional medicine, it’s considered as “Alternative treatment.” Cancer Alternative Medicine consists of treatments that are based on prescientific concepts of human pathology and physiology. Most people who use non-mainstream approaches use them along with conventional treatments. Cancer Alternative Medicine therapies include a varied variety of nutritional products, such as and botanicals dietary supplements, vitamins and herbal supplements

European Oncology Societies: European Society for Gene and Cell TherapyEuropean Society of Oncologic ImagingEuropean Association for Cancer ResearchEuropean Association of Neuro-OncologyDutch Society for Surgical OncologyGerman Society of Radiation OncologyChildhood Cancer Research Group

USA Oncology Societies: American Cancer Society (ACS),  American Society of Clinical Oncology (ASCO)Society of Surgical Oncology (SSO)Colon Cancer AllianceAmerican Childhood Cancer AssociationChildren's Neuroblastoma Cancer FoundationMusculoskeletal Tumor Society

Asian Oncology Societies: Federation of Asian Organizations for Radiation Oncology (ARO)Singapore Society of OncologyAssociation of Radiation Oncologists of IndiaJapanese Breast Cancer SocietyAsian Cancer Foundation.

Track 20: Oncology Nursing

Oncology nursing is an area involving the roles of direct caregiver, educator, consultant, administrator and researcher. oncology and cancer nursing extends to all care delivery settings in which clients experiencing or at hazard for developing most cancers acquire health care, schooling, and counselling for cancer prevention, screening and detection. It additionally entails appropriate screenings and other preventative practices, symptom management, care to preserve as much normal functioning as viable, and supportive measures upon give up of lifestyles. Oncology nursing is a multi-disciplinary team, in a diffusion of settings, from the inpatient ward, to the bone marrow transplant unit, through the network. Oncology nurses frequently serve as your first line of communication, and help coordinate the numerous factors of your care at some stage in most cancers remedy. They will carry out a number of obligations. An oncology nurse gives deal with maximum cancers patients and those at threat for purchasing the ailment. Oncology nurses should control the signs and symptoms of an affected individual’s illness and the issue results of diverse most cancers remedies. They screen bodily conditions, prescribe medication, and administer chemotherapy and unique treatments.

European Oncology Societies: European Society for Gene and Cell Therapy,  UK Oncology Nursing Children’s Cancer and Leukemia Group SocietyEuropean Society of Oncologic ImagingEuropean Association for Cancer ResearchDutch Society for Surgical OncologyGerman Society of Radiation OncologyChildhood Cancer Research Group

USA Oncology Societies: American Association for Cancer Research (AACR)International Agency for Research on Cancer (IARC)American Society of Clinical Oncology (ASCO),  Colon Cancer AllianceAmerican Childhood Cancer AssociationAmerican Society for Radiation Oncology

Asian Oncology Societies: Asian Oncology Nursing Society(AONS)Asian Society of Gynecologic Oncology (ASGO)Federation of Asian Organizations for Radiation Oncology (ARO)Singapore Society of OncologyAssociation of Radiation Oncologists of IndiaJapanese Breast Cancer SocietyAsian Cancer Foundation.

Track 21: Clinical Oncology

Clinical Oncology includes full spectrum of Nonsurgical Cancers including the Chemotherapy, Radiotherapy, Palliative care and Biological targeted therapy. Clinical oncologists treat Solid tumors with Conventional Radiotherapy, Chemotherapy, Brachytherapy, Biological therapy, Molecular targeted therapy and sometimes with multimodality treatments that include the combination of two or more Anti-cancer therapies. Clinical oncologists determine treatment by considering a range of factors including tumor type, the site of the tumor, the stage of the disease and the patient’s general health. They then assess the relative merits of different treatments before presenting these to the patient so that an informed decision can be made. The branch also includes the study of Cancer staging, Cancer epidemiology, Brachytherapy, Cancer biostatistics etc.

European Oncology Societies: Dutch Society for Surgical OncologyGerman Society of Radiation OncologyChildhood Cancer Research GroupAssociation of Population-based Cancer Registries in GermanyFrench Society of Radiation OncologyChildren's Cancer Association

USA Oncology Societies: American Childhood Cancer AssociationAmerican Society for Radiation OncologyChildren's Neuroblastoma Cancer FoundationMusculoskeletal Tumor Society

Asian Oncology Societies: Singapore Society of OncologyAssociation of Radiation Oncologists of IndiaJapanese Breast Cancer SocietyAsian Cancer FoundationJapan Lung Cancer SocietyCancer Relief Society Nepal

Track 22: Surgical Oncology

Among all Anti-cancer therapies, treatment of Cancer by surgery remains a basic method for oncology. Surgery is used to diagnose stage and treat cancer and certain cancer-related symptoms. Surgical oncology is the branch of Oncology that deals with the surgical aspects of cancer including biopsy, cancer staging, and surgical resection of tumors it focuses on the surgical management of tumours, especially cancerous tumours. Surgical oncology is a specialized area of oncology that engages surgeons in the cure and management of cancer. Whether a patient is a candidate for surgery depends on factors such as the type, size, location, grade and stage of the tumour, as well as general health factors such as age, physical fitness and other medical comorbidities. For many patients, surgery will be combined with other cancer treatments such as chemotherapy, radiation therapy or hormone therapy.

European Oncology Societies: European Society for Gene and Cell TherapyInternational Society for Stem Cell Research (ISSCR)UK Oncology Nursing Children’s Cancer and Leukemia Group SocietyEuropean Society of Oncologic ImagingEuropean Association for Cancer ResearchEuropean Association of Neuro-Oncology

USA Oncology Societies: American Cancer Society (ACS)American Association for Cancer Research (AACR)International Agency for Research on Cancer (IARC)American Society of Clinical Oncology (ASCO)Society of Surgical Oncology (SSO)Colon Cancer Alliance

Asian Oncology Societies: Asian Oncology Nursing Society (AONS)Asian Society of Gynecologic Oncology (ASGO)Asian Cancer FoundationJapan Lung Cancer SocietyCancer Relief Society Nepal

 

Track 23: Cancer Prevention & Cure

Cancer prevention is outlined as active measures to decrease the danger of cancer. Most of cancer causes because of environmental risk factors of those environmental factors are governable way decisions. A personality's risk of developing cancer is considerably reduced by healthy behaviour. Cancer prevention analysis includes diagnosing, clinical and change of location analysis with special attention given to molecular discoveries and a stress on building a change of Location Bridge between the fundamental and clinical sciences.

European Oncology Societies: European Society for Gene and Cell TherapyInternational Society for Stem Cell Research (ISSCR)UK Oncology Nursing Children’s Cancer and Leukemia Group SocietyEuropean Society of Oncologic ImagingEuropean Association for Cancer Research

USA Oncology Societies: American Cancer Society (ACS)American Association for Cancer Research (AACR)International Agency for Research on Cancer (IARC)American Society of Clinical Oncology (ASCO)Society of Surgical Oncology (SSO)Colon Cancer Alliance

Asian Oncology Societies: Asian Oncology Nursing Society (AONS)Asian Society of Gynecologic Oncology (ASGO)Asian Society of Head & Neck Oncology (ASHNO)Federation of Asian Organizations for Radiation Oncology (ARO)

Track 24: Cancer Case reports

Cancer has a diversified nature in relation to the organ specificity. Most cancers are a group of more than a hundred diseases that expand throughout time in any of the body’s tissues. Each type of cancer has its particular capabilities; the simple procedures that produce most cancers are pretty comparable in all sorts of the diseases. A case record is the specified document of signs and symptoms, prognosis, remedies of the unique sufferers of positive clinical records with unique healing strategies. As about 7.6 million of latest instances of malignancy documented every year, 1/2 of them are from developing countries. Case reports want to be up to date from all the statistics from the beyond.

European Oncology Societies: Dutch Society for Surgical OncologyGerman Society of Radiation OncologyChildhood Cancer Research GroupAssociation of Population-based Cancer Registries in GermanyFrench Society of Radiation OncologyChildren's Cancer Association

USA Oncology Societies: American Childhood Cancer AssociationAmerican Society for Radiation OncologyChildren's Neuroblastoma Cancer FoundationMusculoskeletal Tumor Society

Asian Oncology Societies: Singapore Society of OncologyAssociation of Radiation Oncologists of IndiaJapanese Breast Cancer SocietyAsian Cancer FoundationJapan Lung Cancer SocietyCancer Relief Society Nepal

Market Analysis Report

Euro Cancer 2019 will be one of the World’s best platforms for Oncologists, radiologists, pathologists, diagnostic councillors, Clinical Researchers, medical professionals, students, non-invasive surgeons, medical device manufacturers and marketing agencies to explore the novel technologies and adapt them for a better prospective future

Now, with the theme Advancement in Cancer Research and Prospects of New Therapeutic Strategies we would be glad to invite all speakers/delegates at this grand event to witness world’s best platform on Oncology and Cancer

These events are known for being a collaborative forum to exchange ideas and network through symposium, panel discussions, poster sessions, and the exhibition.

Target audience

Principle Investigators and Directors, Oncologists, Radiologists, Pathologists, Clinical Researchers, Clinical Coordinators, Scientists, Nurse Practitioners, Group Leaders, Medical Imaging and Clinical Research Association and Societies Professionals, Bio-Medical Company professionals, Young Researchers, Academic educators and students, Medical Imaging Associations and Societies, Clinical Research Associations and Societies, Business Entrepreneurs

Manufacturing Otechnologies Companies Members associated with Oncology Research worldwide

 

Market Analysis Report

The growth of the global market of diagnostic imaging is increased due to the various imaging technologies introduced in the market and awareness of the emergence of early disease diagnosis among the people have led to the increased global market revenue for the medical imaging technology. Medical imaging has led to many improvements in the diagnosis and treatment of diseases in children and adults. The world market for Point of Care (POC) diagnostics by June 2, 2015 is $4,200.  China and India are the emerging markets that have become a business for the companies engaged in the marketing and development of diagnostic imaging systems. The other key players in the global market are Shimadzu Corporation (Japan), Hitachi Medical Corporation (Japan), Philips Healthcare (Netherlands) and Siemens Healthcare (Germany).

Market growth of Oncology Research in last years

Market growth Oncology Research in upcoming years

 

The worldwide market for restorative imaging by 2017 will for the most part become because of developing markets, for example, India, Latin America, Russia, and China. Furthermore, for India, the offers of restorative imaging gear are relied upon to increment from $550 million in 2011 to around $1.27 billion by 2017. Ice and Sullivan orders therapeutic imaging frameworks into two modalities, that is essential and propelled modalities that have about equivalent partakes in the market. Fundamental modalities incorporate, for example, general X-beam, mammographic X-beam and ultrasound and propelled modalities incorporates registered tomography, attractive resonance (MR), and atomic imaging. Essential modalities represented 51 percent of the market income and propelled modalities or 49 percent. 

Economic specialists anticipate that in the coming years propelled therapeutic imaging hardware will be less obtrusive and less demanding to utilize. They additionally expect that later on fabricates of medicinal imaging innovation, the imaging frameworks will create and deliver vitality sparing, cheap and ergonomic therapeutic gear that will include less potential hazard and require little upkeep. In 2012, the income of the worldwide medicinal imaging gear showcase produced $24.1 billion and 61 % of the market income was created from three geographic reasons: North America, Europe and Japan. North America represented 25 percent of the worldwide market income, Europe for 19 percent and Japan for 17 percent. The economic analysts led an investigation in 2013 that the market for therapeutic imaging frameworks will develop from $30.2 billion in 2013 and $32.3 billion in 2014 to $49 billion in 2020. The market specialists from Frost and Sullivan express that GE, Philips and Siemans represented 78 percent of the worldwide market income from medicinal imaging hardware in 2012. Specialists at Harvard Medical School have discovered that length of a patient's healing center stay is diminished by one day for each $385 spent on restorative imaging gear. By 2020, extra sub-atomic imaging strategies will be presented for clinical applications, for example, 7-Tesla imaging and attractive molecule imaging which portrays dynamic procedures inside the body without the need to uncover the patients and inspectors to radiation.

 

The world market investigation for ultrasound by Dec 17, 2014 was $1,500, for MRI by Nov 24, 2014 was $1,500, for sub-atomic imaging by Sep 26, 2012 was $3,995 and for CT frameworks by Dec 1, 2014 was $1,995. The world market examination for medicinal imaging markets ( X-beam, computerized X-beam, CT and other radiography frameworks) by Nov 1, 2011 was $3,500, for (X-beam, CT, MRI, ultrasound, PET, SPECT, others ) by Feb 5, 2014 was $3,995, world market for cardiovascular diagnostics (markets for ECG, imaging, heart POC, differentiate specialists and heart markers) by Jun 25, 2013 was $3,995, for difference operators (X-beam, CT, ultrasound, MRI, PET, SPECT) by Jul 9, 2012 was $3,955. 

As per the new market examination distributed by Transparency Market Research entitled "Computerized Radiology Market evaluated at $9.7 billion in 2012 is relied upon to reach $13.3 billion by 2018" at a compound yearly development rate of 5.4 percent from 2012 to 2018. 

All around, the North America locale is relied upon to be a main position regarding income until 2018 as it holds around 41.9 percent of the income of worldwide advanced radiology piece of the pie. The worldwide advanced radiology market is relied upon to achieve 158,200 units by 2018 as far as volume. 

The worldwide market of attractive reverberation imaging (MRI) values $4.13 billion as of the primary quarter of 2013 and is relied upon to develop at a CAGR of 4.56 percent to reach roughly around $5.24 billion by 2018. 

As indicated by another report by San Jose, Calif – based think-tank Global Industry Analysts, Inc, the worldwide market for mammographic gear is required to reach $610 million by 2018. 

The worldwide market for analytic imaging at a CAGR of 4.2% from 2011 to 2016 is relied upon to reach $26.6 billion by 2016. The driving variables for the development of indicative imaging business sector are expanding maturing populace and advancement of different utilizations of symptomatic imaging. 

As per the statistical surveying firm IMS inquire about, the worldwide market for X-beam gear is required to increment by 18% to reach $12 billion in 2017 as it has achieved the income of $10 billion in 2012.

Conclusion

The Cancer Therapy and Radiation Oncology will play a key role in the future of medical diagnostics and therapeutics according to the market experts. The important growth drivers include the digitization of measurement values, the miniaturization and portability of equipment, hybrid imaging systems, and the use of non-ionizing imaging modalities such as optical and ultrasound systems. Thus, the emergence of new technologies will increase the advancement and market growth of Oncology Research in upcoming years with an aim of patient care.

Past Conference Report

Euro Cancer 2018

Thanks to all our Speakers and conference attendees of Euro Cancer 2018 Conference

29th Euro-Global Summit on Cancer Therapy & Radiation Oncology during July 23-25, 2018 at Rome, Italy. The conference organized with a focus on Scrutinizing Progressive Cancer Research in Diagnosis, Treatment and Prevention” was a great success where eminent keynote speakers from various reputed institutions with their magnificent presence addressed the gathering.

The conference was commenced with an opening ceremony followed by Keynote sessions and followed by series of lectures delivered by both Honourable Guests and members of the Keynote forum. The adepts who promote the theme with their elegant talk were:

  • Jaime Tisnado                          

Virginia Commonwealth University, USA

  • Christopher S Lange

Downstate Medical Center, Brooklyn, NY, USA

  • Carina Mari Aparici

University of California, USA

  • Antonio Gómez-Muñoz

University of the Basque Country, Spain

  • Shinji Osada

Gifu Municipal Hospital, Japan

  • Kang-Yell Choi

Yonsei University, South Korea

  • Rufadie Maxhuni

Clinical University Center of Kosovo, Pristina


Your rejoinder is our inspiration; keeping this motto in mind and being witnessed the triumph of Euro Cancer 2018, we would like to announce the commencement of the “34th Euro-Global Summit on Cancer Therapy & Radiation Oncology” to be held during July 25-27,2019 at London, UK. We welcome all the eminent researchers, students and delegate participants to take part in this upcoming conference to witness invaluable scientific discussions and contribute to the future innovations in the field of Oncology Research.

For more details: https://eurocancer.expertconferences.org/

 

Let us meet again @ Euro Cancer 2019


Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date

Speaker Opportunity

Supported By

Journal of Cancer Science and Therapy Journal of Integrative Oncology Journal of Carcinogenesis and Mutagenesis

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by


Media partners & Collaborators & Sponsors

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner